Search Results

You are looking at 121 - 130 of 500 items for :

  • Refine by Access: Content accessible to Me x
Clear All
Full access

Michelle E. Melisko and Joseph B. Narus

not so obvious ways,” stated Dr. Melisko. For instance, adverse effects of treatment may include reduced sexual desire, decreased libido, and fatigue. In addition, “Endocrine therapy has a profound impact on both men and women,” she added. Along with

Full access

Somasundaram Subramaniam, Jason A. Zell, and Pamela L. Kunz

therefore initiated therapy with everolimus. After starting everolimus he noted improvement in pain and diarrhea. He had side effects of fatigue, stomatitis, a pustular rash on his fingers and scalp, and mild thrombocytopenia. He had been on everolimus for

Full access

Javaughn Corey R. Gray, Jongho Kim, Michael Digianvittorio, Nancy K. Feeley, Paul J. Scheel, Stanley S. Siegelman, Elliot K. Fishman, and Steven P. Rowe

hypertension, chronic kidney disease, anemia, and pericardial effusion initially presented with severe fatigue, cognitive impairment, and diffuse bone pain. He also reported muscle pain in his thighs and calves, diminished appetite, and severe lethargy. In a

Full access

Linda Overholser and Carlin Callaway

unmet needs after treatment. Many patients have also suffered physical side effects and have seen the relationships in their lives undergo dramatic shifts. Patients’ needs often relate to quality of life (fatigue, fear of recurrence) and/or their ability

Full access

David S. Ettinger

%, respectively. The most common side effects of nivolumab were fatigue, musculoskeletal pain, decreased appetite, cough, and constipation. Eighty-three patients had tumor samples suitable for PD-L1 expression analysis. Across the prespecified expression levels

Full access

Thomas Olencki

SCC. A phase II study was conducted at his center, but was discontinued due to overwhelming fatigue, anorexia, weight loss, and pleural effusion. Other therapies appear to offer more promise in the treatment of cutaneous SCC. Dr. Olencki discussed

Full access

-Ineligible, Newly Diagnosed Multiple Myeloma In the first case study, a 75-year-old man presented with new back pain and fatigue. The patient was able to perform all activities of daily living and resided approximately 70 miles away from the treatment center

Full access

Presenter: Stephen D. Smith

.4 months. The safety of ibrutinib in MZL is similar to that seen in other diseases. Frequently occurring adverse effects include fatigue, diarrhea, and anemia. Atrial fibrillation should be a reason for concern in patients with cardiac history, said Dr

Full access

Jimmie C. Holland and Barry D. Bultz

. 16. Carlson LE Angen M Cullum J . High levels of untreated distress and fatigue in cancer patients . Br J Cancer 2004 ; 90 : 2297 – 2304 . 17. Carlson LE Bultz BD . Cancer distress screening. Needs, models, and methods . J

Full access

Katrine Løppenthin, Christoffer Johansen, Matilde Bille Larsen, Birgitte Hysse Forchhammer, Jannick Brennum, Karin Piil, Neil Aaronson, Birthe Krogh Rasmussen, and Pernille Bidstrup

and its treatment. 2 , 3 Frequent symptoms include global cerebral manifestations (fatigue, nausea, headache, and confusion), focal symptoms (hemiparesis, paresthesia, motor control deficiency, visual disturbances, seizures, and speech difficulties